Current Neuro-Oncology

Volume 11 Number 6
30 June 2009

Home > Publications > Current Neuro-Oncology > Volume 11, Year 2009 > Number 6, 30 June

Chiewvit P, Danchaivijitr N, Sirivitmaitrie K, Chiewvit S, Thephamongkhol K.
Does magnetic resonance imaging give value-added than bone scintigraphy in the detection of vertebral metastasis?
J Med Assoc Thai. 2009 Jun;92(6):818-29. PMID: 19530588. Observational study. ˍ

El Khashab M, Gargan L, Margraf L, Koral K, Nejat F, Swift D, Weprin B, Bowers DC.
Predictors of tumor progression among children with gangliogliomas. Clinical article.
J Neurosurg Pediatr. 2009 Jun;3(6):461-6. doi: 10.3171/2009.2.PEDS0861. PMID: 19485728. Observational study. ˍ

Olufemi Adeleye A, Balogun JA.
Bilateral deafness and blindness from a IVth ventricular medulloblastoma.
Br J Neurosurg. 2009 Jun;23(3):315-7. doi: 10.1080/02688690802512858. PMID: 19533466. Case report. ˍ

Benesch M, Moser A, Sovinz P, Lackner H, Schwinger W, Eder H, Urban C.
Medulloblastoma in a child with down syndrome: long-term remission with multimodality treatment.
Pediatr Blood Cancer. 2009 June 1;53(6):1150-1. doi: 10.1002/pbc.22109. PMID: 19489060. Case report. ˍ

Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, Hjelmeland AB, Rich JN.
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.
Cancer Cell. 2009 Jun 2;15(6):501-13. doi: 10.1016/j.ccr.2009.03.018. PMID: 19477429. Laboratory investigation. ˍ

Neyns B, Sadones J, Joosens E, Bouttens F, Verbeke L, Baurain JF, D'Hondt L, Strauven T, Chaskis C, In't Veld P, Michotte A, De Greve J.
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma.
Ann Oncol. 2009 2009 Jun 2;20(9):1596-1603. doi: 10.1093/annonc/mdp032. PMID: 19491283. Interventional study. ˍ

Reimers TS, Mortensen EL, Nysom K, Schmiegelow K.
Health-related quality of life in long-term survivors of childhood brain tumors.
Pediatr Blood Cancer. 2009 Jun 4;53(6):1086-91. doi: 10.1002/pbc.22122. PMID: 19499581. Observational study. ˍ

Fu J, Liu ZG, Liu XM, Chen FR, Shi HL, Pangjesse CS, Ng HK, Chen ZP.
Glioblastoma stem cells resistant to temozolomide-induced autophagy.
Chin Med J (Engl). 2009 Jun 5;122(11):1255-9. doi: 10.3760/cma.j.issn.0366-6999.2009.11.004. PMID: 19567133. Laboratory investigation. ˍ

*Gao S, Yang XJ, Zhang WG, Ji YW, Pan Q.
Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro.
Chin Med J (Engl). 2009 Jun 5;122(11):1260-6. doi: 10.3760/cma.j.issn.0366-6999.2009.11.005. PMID: 19567134. Laboratory investigation. ˍ

Li SW, Qiu XG, Chen BS, Zhang W, Ren H, Wang ZC, Jiang T.
Prognostic factors influencing clinical outcomes of glioblastoma multiforme.
Chin Med J (Engl). 2009 Jun 5;122(11):1245-9. doi: 10.3760/cma.j.issn.0366-6999.2009.11.002. PMID: 19567131. Observational study. ˍ

Thiessen B, Stewart C, Tsao M, Kamel-Reid S, Schaiquevich P, Mason W, Easaw J, Belanger K, Forsyth P, McIntosh L, Eisenhauer E.
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.
Cancer Chemother Pharmacol. 2009 Jun 5;65(2):353-61. doi: 10.1007/s00280-009-1041-6. PMID: 19499221. Interventional study. ˍ

Zhang W, Qiu XG, Chen BS, Li SW, Cui Y, Ren H, Jiang T.
Antiangiogenic therapy with bevacizumab in recurrent malignant gliomas: analysis of the response and core pathway aberrations.
Chin Med J (Engl). 2009 Jun 5;122(11):1250-4. doi: 10.3760/cma.j.issn.0366-6999.2009.11.003. PMID: 19567132. Observational study. ˍ

Baruchel S, Sharp JR, Bartels U, Hukin J, Odame I, Portwine C, Strother D, Fryer C, Halton J, Egorin MJ, Reis RM, Martinho O, Stempak D, Hawkins C, Gammon J, Bouffet E.
A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours.
Eur J Cancer. 2009 Jun 6;45(13):2352-9. doi: 10.1016/j.ejca.2009.05.008. PMID: 19505817. Interventional study. ˍ

Pellegatta S, Finocchiaro G.
Dendritic cell vaccines for cancer stem cells.
Methods Mol Biol. 2009 Jun 7;568:233-47. doi: 10.1007/978-1-59745-280-9_15. PMID: 19582431. Laboratory investigation protocol. ˍ

Clarke JL, Iwamoto FM, Sul J, Panageas K, Lassman AB, DeAngelis LM, Hormigo A, Nolan CP, Gavrilovic I, Karimi S, Abrey LE.
Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.
J Clin Oncol. 2009 Jun 8;27(23):3861-7. doi: 10.1200/JCO.2008.20.7944. PMID: 19506159. Interventional study. ˍ

Affronti ML, Heery CR, Herndon JE 2nd, Rich JN, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH, Bigner DD, Friedman HS.
Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
Cancer. 2009 June 9;115(15):3501-11. doi: 10.1002/cncr.24398. PMID: 19514083. Observational study. ˍ

Brandes AA, Franceschi E, Tosoni A, Benevento F, Scopece L, Mazzocchi V, Bacci A, Agati R, Calbucci F, Ermani M.
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.
Cancer. 2009 June 9;115(15):3512-8. doi: 10.1002/cncr.24406. PMID: 19514084. Observational study. ˍ

Raza S, Donach M.
Bevacizumab in adult malignant brainstem gliomas.
J Neurooncol. 2009 June 9;95(2):299-300. doi: 10.1007/s11060-009-9933-1. PMID: 19506812. Letter to the editor. ˍ
Related article:
Torcuator R, Zuniga R, Loutfi R, Mikkelsen T.
Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report.
J Neurooncol. 2009 Jan 13;93(3):409-12. doi: 10.1007/s11060-008-9782-3. PMID: 19139822. Case report. ˍ

*D'Urso OF, D'Urso PI, Marsigliante S, Storelli C, Luzi G, Gianfreda CD, Montinaro A, Distante A, Ciappetta P.
Correlative analysis of gene expression profile and prognosis in patients with gliomatosis cerebri.
Cancer. 2009 June 10;115(16):3749-57. doi: 10.1002/cncr.24435. PMID: 19517475. Laboratory investigation. ˍ

Rachinger W, Grau S, Holtmannspötter M, Herms J, Tonn JC, Kreth FW.
Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only.
J Neurol Neurosurg Psychiatry. 2009 Jun 10;80(10):1134-9. doi: 10.1136/jnnp.2009.174250. PMID: 19520698. Observational study. ˍ

Frange P, Alapetite C, Gaboriaud G, Bours D, Zucker JM, Zerah M, Brisse H, Chevignard M, Mosseri V, Bouffet E, Doz F.
From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980-2000).
J Neurooncol. 2009 Jun 12;95(2):271-279. doi: 10.1007/s11060-009-9927-z. PMID: 19521664. Observational study. ˍ

Ward E, Hopkins M, Arbuckle L, Williams N, Forsythe L, Bujkiewicz S, Pizer B, Estlin E, Picton S.
Nutritional problems in children treated for medulloblastoma: implications for enteral nutrition support.
Pediatr Blood Cancer. 2009 June 15;53(4):570-5. doi: 10.1002/pbc.22092. PMID: 19530236. Observational study. ˍ

Corn BW, Wang M, Fox S, Michalski J, Purdy J, Simpson J, Kresl J, Curran WJ Jr, Diaz A, Mehta M, Movsas B.
Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03.
J Neurooncol. 2009 Jun 16;95(2):247-257. doi: 10.1007/s11060-009-9923-3. PMID: 19533025. Interventional study. ˍ

Kuttesch JF Jr, Krailo MD, Madden T, Johansen M, Bleyer A; Children's Oncology Group.
Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study.
Pediatr Blood Cancer. 2009 June 16;53(4):590-3. doi: 10.1002/pbc.22133. PMID: 19533657. Interventional study. ˍ

Moreno L, Bautista FJ, Zacharoulis S.
Outcome of teenagers and young adults with ependymoma: the Royal Marsden experience.
Childs Nerv Syst. 2009 Jun 16;25(9):1047-52. doi: 10.1007/s00381-009-0920-9. PMID: 19533154. Observational study. ˍ

Sharma A, Gupta D, Mohanti BK, Thulkar S, Dwary A, Goyal S, Muzumder S, Das P.
Non-Hodgkin lymphoma following temozolomide.
Pediatr Blood Cancer. 2009 June 16;53(4):661-2. doi: 10.1002/pbc.22090. PMID: 19533661. Case report. ˍ

Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, Hudson MM, Donaldson SS, King AA, Stovall M, Krull KR, Robison LL, Packer RJ.
Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.
J Natl Cancer Inst. 2009 Jun 17;101(13):946-58. doi: 10.1093/jnci/djp148. PMID: 19535780. Observational study. ˍ

Ellis JA, Waziri A, Balmaceda C, Canoll P, Bruce JN, Sisti MB.
Rapid recurrence and malignant transformation of pilocytic astrocytoma in adult patients.
J Neurooncol. 2009 Jun 17;95(3):377-382. doi: 10.1007/s11060-009-9935-z. PMID: 19533024. Observational study. ˍ

Forinder U, Lindahl Norberg A.
"Now we have to cope with the rest of our lives". Existential issues related to parenting a child surviving a brain tumour.
Support Care Cancer. 2009 Jun 17;18(5):543-51. doi: 10.1007/s00520-009-0678-3. PMID: 19669170. Observational study. ˍ

Murat A, Migliavacca E, Hussain SF, Heimberger AB, Desbaillets I, Hamou MF, Rüegg C, Stupp R, Delorenzi M, Hegi ME.
Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.
PLoS One. 2009 Jun 17;4(6):e5947. doi: 10.1371/journal.pone.0005947. PMID: 19536297. Laboratory investigation. ˍ

Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH, Sampson JH, McLendon RE, Herndon JE 2nd, Friedman HS.
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
J Neurooncol. 2009 Jun 17;95(3):393-400. doi: 10.1007/s11060-009-9937-x. PMID: 19533023. Interventional study. ˍ

Schomas DA, Laack NN, Brown PD.
Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.
Cancer. 2009 June 17;115(17):3969-78. doi: 10.1002/cncr.24444. PMID: 19536875. Observational study. ˍ

Gauden AJ, Hunn A, Erasmus A, Waites P, Dubey A, Gauden SJ.
Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre.
J Clin Neurosci. 2009 Jun 18;16(9):1174-9. doi: 10.1016/j.jocn.2008.12.008. PMID: 19540125. Observational study. ˍ

Korshunov A, Meyer J, Capper D, Christians A, Remke M, Witt H, Pfister S, von Deimling A, Hartmann C.
Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Acta Neuropathol. 2009 Jun 19;118(3):401-5. doi: 10.1007/s00401-009-0550-z. PMID: 19543740. Laboratory investigation. ˍ

Budrukkar A, Jalali R, Dutta D, Sarin R, Devlekar R, Parab S, Kakde A.
Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice.
J Neurooncol. 2009 Jun 23;95(3):413-419. doi: 10.1007/s11060-009-9939-8. PMID: 19548070. Observational study. ˍ

Mehrotra N, Shamji MF, Vassilyadi M, Ventureyra EC.
Intracranial tumors in first year of life: the CHEO experience.
Childs Nerv Syst. 2009 Jun 24;25(12):1563-9. doi: 10.1007/s00381-009-0936-1. PMID: 19551387. Observational study. ˍ

Behdad A, Perry A.
Central nervous system primitive neuroectodermal tumors: a clinicopathologic and genetic study of 33 cases.
Brain Pathol. 2009 Jun 25;20(2):441-50. doi: 10.1111/j.1750-3639.2009.00314.x. PMID: 19725831. Observational study. ˍ

Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, Reifenberger G, von Deimling A.
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Acta Neuropathol. 2009 Jun 25;118(4):469-74. doi: 10.1007/s00401-009-0561-9. PMID: 19554337. Laboratory investigation. ˍ

*Hottinger AF, Yoon H, DeAngelis LM, Abrey LE.
Neurological outcome of long-term glioblastoma survivors.
J Neurooncol. 2009 Jun 26;95(3):301-305. doi: 10.1007/s11060-009-9946-9. PMID: 19557499. Observational study. ˍ

Shaffer R, Nichol AM, Vollans E, Fong M, Nakano S, Moiseenko V, Schmuland M, Ma R, McKenzie M, Otto K.
A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas.
Int J Radiat Oncol Biol Phys. 2009 Jun 27;76(4):1177-84. doi: 10.1016/j.ijrobp.2009.03.013. PMID: 19560880. Observational study. ˍ

Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Friedman AH, Herndon JE 2nd, Marcello J, Norfleet JA, McLendon RE, Sampson JH, Friedman HS.
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
J Neurooncol. 2010 Jun 28;96(2):219-30. doi: 10.1007/s11060-009-9950-0. PMID: 19562254. Interventional study. ˍ

Jang SY, Kong MH, Song KY, Frazee JG.
Intracranial Metastases of Cervical Intramedullary Low-Grade Astrocytoma without Malignant Transformation in Adult.
J Korean Neurosurg Soc. 2009 Jun 30;45(6):381-5. doi: 10.3340/jkns.2009.45.6.381. PMID: 19609424. Case report. ˍ